Patents by Inventor Arjan van der Flier

Arjan van der Flier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210246212
    Abstract: Antibodies and antibody fragments that specifically bind to glycoprotein IIb/IIIa (GPIIb/IIIa) are disclosed. Chimeric molecules comprising such antibodies or antigen-binding fragments are also disclosed. In addition, methods of using the disclosed antibodies, antibody fragments, and chimeric molecules, e.g., to target agents to platelets and for the treatment or prevention of diseases or disorders are provided.
    Type: Application
    Filed: November 12, 2020
    Publication date: August 12, 2021
    Inventors: Joe Salas, Karl Hanf, Arjan van der Flier, Bradley R. Pearse
  • Publication number: 20210238259
    Abstract: The present disclosure provides Factor IX (FIX) fusion proteins comprising at least one heterologous moiety, such as an XTEN. The present disclosure further discloses methods of making and using the FIX fusion proteins.
    Type: Application
    Filed: January 31, 2018
    Publication date: August 5, 2021
    Inventors: Arjan VAN DER FLIER, Zhiqian LIU, David R. LIGHT, Ekta Seth CHHABRA, Tongyao LIU, Robert T. PETERS, John KULMAN, Ayman ISMAIL
  • Publication number: 20210032616
    Abstract: The present invention provides Factor IX (FIX) fusion proteins comprising at least one heterologous moiety, such as an XTEN. The present invention further discloses methods of making and using the FIX fusion proteins.
    Type: Application
    Filed: July 6, 2020
    Publication date: February 4, 2021
    Inventors: Zhiqian LIU, Arjan VAN DER FLIER, David R. LIGHT, Ekta Seth CHHABRA, Tongyao LIU, Robert T. PETERS, John KULMAN, Ayman ISMAIL
  • Patent number: 10875924
    Abstract: Antibodies and antibody fragments that specifically bind to glycoprotein IIb/IIIa (GPIIb/IIIa) are disclosed. Chimeric molecules comprising such antibodies or antigen-binding fragments are also disclosed. In addition, methods of using the disclosed antibodies, antibody fragments, and chimeric molecules, e.g., to target agents to platelets and for the treatment or prevention of diseases or disorders are provided.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: December 29, 2020
    Assignee: Biogen MA Inc.
    Inventors: Joe Salas, Karl Hanf, Arjan van der Flier, Bradley R. Pearse
  • Patent number: 10745680
    Abstract: The present invention provides Factor IX (FIX) fusion proteins comprising at least one heterologous moiety, such as an XTEN. The present invention further discloses methods of making and using the FIX fusion proteins.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: August 18, 2020
    Assignee: Bioverativ Therapeutics Inc.
    Inventors: Zhiqian Liu, Arjan Van Der Flier, David R. Light, Ekta Seth Chhabra, Tongyao Liu, Robert T. Peters, John Kulman, Ayman Ismail
  • Publication number: 20170355771
    Abstract: Antibodies and antibody fragments that specifically bind to glycoprotein IIb/IIIa (GPIIb/IIIa) are disclosed. Chimeric molecules comprising such antibodies or antigen-binding fragments are also disclosed. In addition, methods of using the disclosed antibodies, antibody fragments, and chimeric molecules, e.g., to target agents to platelets and for the treatment or prevention of diseases or disorders are provided.
    Type: Application
    Filed: October 23, 2015
    Publication date: December 14, 2017
    Applicant: Biogen MA Inc.
    Inventors: Joe Salas, Karl Hanf, Arjan van der Flier, Bradley R. Pearse